Testing Lung Cancer Patients’ and Oncologists’ Experience with Lalaby

Lalaby is a novel non-invasive monitoring tool for Quality of Life (QoL) through the patients’ Smartphones, which is currently testing on a lung cancer patient at Hospital Universitario Doctor Peset de Valencia. The first results have been recently published in the International Journal of Human–Computer Interaction under the title “Testing Lung Cancer Patients’ and Oncologists’ Experience with the Lalaby App for Monitoring the Quality of Life through Mobile Sensors and Integrated Questionnaires”.

The serial objective and subjective information in real-time on the patient’s QoL, provided by the Lalaby app, could contribute to more personalized, efficient, and effective therapeutic decision-making by oncologists. With the Lalaby app, patients continuously monitor their QoL between consultations, which could positively impact their treatment, management of their symptoms, peace of mind, and satisfaction with the medical care received. In addition, the Lalaby app contributes to achieving the Sustainable Development Goal (SDG) corresponding to “3. Health & Wellness”.

More information at http://www.lalaby.es.

Reference

Sabina Asensio-Cuesta, Ángel Sánchez-García, Teresa Soria Comes, Inmaculada Maestu, Maria Martín Ureste, J. Alberto Conejero & Juan M. García-Gómez (2022) Testing Lung Cancer Patients’ and Oncologists’ Experience with the Lalaby App for Monitoring the Quality of Life through Mobile Sensors and Integrated Questionnaires, International Journal of Human-Computer Interaction, DOI: 10.1080/10447318.2022.2121561